Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Front Psychiatry ; 9: 552, 2018.
Artículo en Inglés | MEDLINE | ID: mdl-30510519

RESUMEN

Background: Metabolic factors in the kynurenine pathway (KP) have been widely accepted as being a major mechanism in Major Depressive Disorder (MDD). However, the effects of these metabolites on the degree and pattern of MDD are still poorly understood, partly due to the elusiveness of the level of metabolites when diagnosing depression. This study aimed to explore a novel diagnostic method analyzing peripheral blood with mass spectrometry to assess metabolites from KP in patients with MDD and Bipolar Depression (BD). Methods: Thirty-three patients with MDD, 20 patients with BD, and 23 healthy control participants were enrolled Metabolic factors of KP from plasma including tryptophan (TRP), kynurenine (KYN), kynurenic acid (KYNA), and quinolinic acid (QUIN) were analyzed by UPLC-3Q-MS, and levels compared across three groups. Correlation between HAMD scores and metabolite levels conducted. Receiver operating characteristic (ROC) curve was used to determine the diagnostic value of metabolic factors in MDD. Results: Levels of KYNA, QUIN, KYNA/QUIN, and KYNA/KYN were statistically different across the three groups (P < 0.05); HAMD scores and TRP, KYN, KYNA/QUIN levels were negatively correlated in the MDD group (r = -0.633, -0.477, -0.418, P < 0.05); Accuracy of KYNA diagnosing MDD was 82.5% with the optimal diagnostic value being 15.48 ng/ml. Diagnostic accuracy was increased to 83.6% when KYNA and QUIN levels were used in combination. Conclusion: This results indicate that metabolic factors of KP play a crucial role in the occurrence and development of MDD, supporting the metabolic imbalance hypothesis of MDD. Furthermore, our study also provides a new diagnostic method to study MDD based on plasma KYNA level, and suggests that KYNA would be a potential biomarker in diagnosing depression patients.

2.
J Sep Sci ; 40(8): 1674-1685, 2017 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-28211639

RESUMEN

It is difficult to identify unknown impurities in nucleotide analogues by mass spectrometry because mass-spectrometry-incompatible mobile phases need to be used to separate the major ingredient from impurities. In this study, vidarabine monophosphate was selected, and unknown impurities were identified by online heart-cutting two-dimensional high-performance liquid chromatography and linear ion trap mass spectrometry. The one-dimensional reversed-phase column was filled with a mobile phase containing nonvolatile salt. In two-dimensional high-performance liquid chromatography, we used an Acclaim Q1 column with volatile salt, and the detection wavelength was 260 nm. The mass spectrum was scanned in positive- and negative-ion mode. The online heart-cutting and online demineralization technique ensured that the mobile phase was compatible with mass spectrometry; seven impurities were identified by MS2 and MS3 fragments. The mass fragmentation patterns of these impurities were investigated. The two isomers were semiprepared and complemented by nuclear magnetic resonance. The results were further compared with those of normal-phase high-performance liquid chromatography with mass spectrometry. The online heart-cutting two-dimensional high-performance liquid chromatography with mass spectrometry was superior in identifying more impurities. The method solves the problem of incompatibility between the mobile phase and mass spectrometry, so it is suitable for identifying unknown impurities. This method may also be used for investigating impurities in other nucleotide analogues.


Asunto(s)
Cromatografía Líquida de Alta Presión , Contaminación de Medicamentos , Espectrometría de Masas , Fosfato de Vidarabina/análisis
3.
Artículo en Inglés | MEDLINE | ID: mdl-26863072

RESUMEN

Mass spectrometry has been applied to the targeted analysis of commonly used additives (such as Irganox 1010, Irganox 1076, Irgafos 168, etc.) in plastic materials, but a fast and straightforward method for the non-targeted identification and quantification of unusual or potentially new antioxidant additives is still unavailable. In this study, a novel and simple method for the identification and quantification of unknown antioxidant additives in plastic food packaging using ultrasonic extraction and ultra-performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry has been developed. A method for the Irganox series analyzed here has not been reported previously. Unknown antioxidant additives have been identified by accurate m/z determination, MS(2) fragments and comparison with synthesized standards. The mass fragmentation patterns and structural assignments of these antioxidants have been studied. Parameters affecting the efficiency of the process, such as extraction solvents, extraction volume, extraction time and chromatographic conditions, have been studied and optimized. Ultrasonic extraction of plastic materials (40 mg) with dichloromethane (0.5 mL) at 25 °C was applied as optimal. Limits of detection of the target additives ranged from 0.5 ng g(-1) to 1.5 ng g(-1), and the detection was linear over the range studied (0.01-1.5 µg mg(-1), r(2)>0.99). The accuracy of the method has been tested by relative recovery experiments with spiked samples, with results ranging from 94.3% to 104.8%, and the precision (relative standard deviation) was within 11.0% (n=3). Finally, the method has been successfully applied to the determination of antioxidants in several real plastic samples.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...